Intracellular Th Stock Widgets and Gadgets
| ITCI Stock | USD 74.54 2.17 3.00% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ITCI Intracellular Th
- Latest 10 Best Performing Biotech ETFs in 2024
- ITCI 74.54 2.17
- Low 72.02
- High 75.14
- Alpha 0.17
- Beta 1.08
- Return On Equity -0.22
- Return On Asset -0.13
- Profit Margin (0.30) %
- Operating Margin (0.26) %
- Current Valuation 6.74 B
- Shares Outstanding 97.48 M
- Shares Owned By Insiders 2.49 %
- Shares Owned By Institutions 98.60 %
- Number Of Shares Shorted 3.47 M
- Price To Earning (6.56) X
- Price To Book 10.78 X
- Price To Sales 13.73 X
- Revenue 462.18 M
- Gross Profit 95.16 M
- EBITDA (158.85 M)
- Net Income (139.67 M)
- Cash And Equivalents 628.74 M
- Cash Per Share 6.64 X
- Total Debt 16.94 M
- Debt To Equity 0.04 %
- Current Ratio 9.81 X
- Book Value Per Share 6.14 X
- Cash Flow From Operations (124.2 M)
- Short Ratio 5.29 X
- Earnings Per Share (1.46) X
- Target Price 90.04
- Number Of Employees 610
- Beta 1.01
- Market Capitalization 7.27 B
- Total Asset 728.29 M
- Retained Earnings (1.62 B)
- Working Capital 544.25 M
- Current Asset 541.82 M
- Current Liabilities 140.69 M
- Net Asset 728.29 M
- Accumulation Distribution 0.0415
- Daily Balance Of Power 0.6955
- Rate Of Daily Change 1.03
- Day Median Price 73.58
- Day Typical Price 73.9
- Market Facilitation Index 3.12
- Price Action Indicator 2.05
- Period Momentum Indicator 2.17
Market Snapshot Widget Example
DAX Index Germany | 17,861 0.70 | |
Taiwan Weighted Taiwan | 19,411 0.59 | |
PSI 20 Stock Portugal | 6,515 3.50 | |
CROBEX Croatia | 2,803 0.14 | |
Budapest SE Hungary | 65,126 0.12 | |
IDX 30 Jakarta Indonesia | 467.48 0.14 | |
ISEQ 20 Price Ireland | 1,646 0.05 | |
NYSE Comp USA | 17,602 0.82 | |
Tel Aviv 35 Israel | 1,912 0.55 | |
Coreshares Index Tracker South Afric | 1,026 0.59 | |
IPC MEXICO Mexico | 56,552 1.23 | |
KL Technology Malaysia | 62.69 0.14 | |
IBEX 35 Index Spain | 10,890 1.50 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,554 0.49 | |
SPASX Dividend Opportunities Australia | 1,655 0.68 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.11 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,290 0.01 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,173 0.06 | |
Basic Materials Brazil | 5,966 0.05 | |
Swiss Leader Price Switzerland | 1,847 0.38 | |
Fondo Mutuo ETF Chile | 1,407 0.21 | |
Athens General Comp Greece | 1,420 1.99 | |
Stock Exchange Of Thailand | 1,350 1.31 | |
PX Prague Stock Czech Repub | 1,551 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,444 0.02 | |
WIG 30 Poland | 3,102 1.72 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Intracellular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Intracellular
Compare Intracellular To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Intracellular Th information on this page should be used as a complementary analysis to other Intracellular's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Intracellular Stock analysis
When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Intracellular's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Revenue Per Share 4.843 | Quarterly Revenue Growth 0.503 | Return On Assets (0.13) | Return On Equity (0.22) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.